{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T06:45:38Z","timestamp":1778741138587,"version":"3.51.4"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"11-12","license":[{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s10495-024-02017-5","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T21:01:46Z","timestamp":1725656506000},"page":"1856-1857","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Is long-term administration of PLD-pegylated liposomal doxorubicin able to induce oral cancer?"],"prefix":"10.1007","volume":"29","author":[{"given":"Arjun","family":"Pandian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azhagu Madhavan","family":"Sivalingam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,6]]},"reference":[{"key":"2017_CR1","doi-asserted-by":"crossref","unstructured":"Bourell L, Jung C, Kerr R et al (2011) Oral squamous cell malignancy Associated with Long-Term Pegylated Liposomal Doxorubicin Treatment for Ovarian Cancer. 69:e4","DOI":"10.1016\/j.joms.2011.06.026"},{"key":"2017_CR2","doi-asserted-by":"crossref","unstructured":"Holmes BJ, Wenig BMJAoDP (2019). Virus-associated carcinomas of the head & neck: Update from the 2017 WHO classification. 38:29\u201342","DOI":"10.1016\/j.anndiagpath.2018.10.008"},{"key":"2017_CR3","doi-asserted-by":"crossref","unstructured":"Nishimura M, Nomura H, Omi M, Netsu S, Sato Y, Kanao HJOMCR (2022) A case of tongue cancer manifesting from oral leukoplakia after long-term administration of pegylated liposomal doxorubicin. 2022:omac042","DOI":"10.1093\/omcr\/omac042"},{"key":"2017_CR4","doi-asserted-by":"crossref","unstructured":"Grenader T, Goldberg A, Gabizon AJA-cd (2010) Monitoring long-term treatment with pegylated liposomal doxorubicin: how important is intensive cardiac follow-up? 21:868\u2013871","DOI":"10.1097\/CAD.0b013e32833dc3c4"},{"key":"2017_CR5","doi-asserted-by":"crossref","unstructured":"Cannon TL, Lai DW, Hirsch D et al (2012) Squamous cell carcinoma of the oral cavity in nonsmoking women: a new and unusual complication of chemotherapy for recurrent ovarian cancer? 17:1541\u20131546","DOI":"10.1634\/theoncologist.2011-0216"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-024-02017-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-024-02017-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-024-02017-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T15:05:09Z","timestamp":1731164709000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10495-024-02017-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,6]]},"references-count":5,"journal-issue":{"issue":"11-12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["2017"],"URL":"https:\/\/doi.org\/10.1007\/s10495-024-02017-5","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,6]]},"assertion":[{"value":"1 September 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}